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Received May 11, 2011; accepted November 17, 2011AbstractBackground: Information related to histamine-induced cellular responses in C6 glioma cells through second messenger pathways has not
been fully studied, especially the involvement of arachidonic acid (AA) metabolism. In addition, specific labeled ligand binding to
histamine receptor sites still needs to be clarified.
Methods: Labeled mepyramine ligand was used to study its binding sites; [3H] inositol was used to detect inositol 4-phosphate (IP1) formation,
and fura-2/AM was used to detect intracellular free calcium ion ([Ca2þ]i) level activated by the phosphatidylinositol-phospholipase C (PI-PLC)
pathway. Also, labeled AA was used to detect the metabolism of AA and its metabolites release via the activation of phospholipase A2 in the
presence of histamine.
Results: C6 glioma cells incubated with histamine in the presence of 10 mM LiCl for 60 minutes induced an increase of IP1 and
glycerophosphoric-inositol (GPI) accumulation. In addition, histamine caused an increase of extracellular AA with its metabolite release,
eliciting a transient and sustained increase of free [Ca2þ]i. The sustained increase of [Ca2þ]i was almost or completely blocked by La3þ and
excess ethylene diamine tetraacetic acid. The calcium ion influx associated with the sustained phase required the presence of histamine on the
receptor sites, and could be blocked by a H1 antagonist, chlorpheniramine.
Conclusion: C6 glioma cells possess histamine H1 receptors that have affinity towards [
3H]mepyramine binding, and are coupled to PI-PLC to
generate inositol phosphates and to increase [Ca2þ]i, and they are coupled to phospholipase A2 (PLA2) to generate GPI and AA with its
metabolite release. The transient increase in [Ca2þ]i can be attributed to Ca2þ release from intracellular stores, whereas the sustained increase in
[Ca2þ]i is due to influx of extracellular calcium ions. The sustained increase in [Ca2þ]i plays a role in the activation of histamine receptor-
coupled PLA2.
Copyright  2012 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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The C6 glioma cell line was established around 1968,1 and
it has been used for physiologic and pharmacologic studies
because this cell line, having a glial cell origin, contains many* Corresponding author. Dr. Jiann-Wu Wei, Pharmacology, Ricerca-Taiwan,
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doi:10.1016/j.jcma.2012.02.014types of receptors such as adrenergic, serotonergic, muscarinic,
adenosine 50-triphosphate (ATP), bradykinin, and endothelin.2e4
For the histaminergic system, Peakman and Hill5 reported that
histamine caused an increase in [3H] phosphatidylinositol (PI)
turnover and inositol 4-phosphate (IP1) accumulation; however,
an apparent lack of endogenous histamine H1 receptors in
C6 cells was reported by Liu and others6 and Fujimoto and
colleagues.7 Therefore, it was interesting to know if histamine-
mediated signal transduction system can still be detected in
this cell line or not.hinese Medical Association. All rights reserved.
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stimulation resulted in a pronounced release of arachidonic
acid (AA) in smooth muscle cells of the DDT1 MF2 cell line.8
In addition, reports showed that dysregulation of AA metab-
olism plays an important role in influencing critical aspects
of tumorigenesis.9 Furthermore, some evidence suggested
a crucial role of prostaglandin E2, a metabolic product of AA,
in the control of growth, survival, and angiogenic potential of
tumor cells.10 We then decided to use C6 glioma cancer cells
to see if there is a link between AA metabolism and histamine
interacting with its receptor site.
Little information was found about histamine-treated cells
possibly having an alternative pathway of AA metabolism,
which is closely linked to its inflammatory role, so it is worth
conducting more studies on this issue. At the beginning of this
study, we observed a more than 11-fold increase on IP1
accumulation with the use of [3H] labeled inositol under the
maximal stimulation of histamine (at 100 mM), which could be
blocked by histamine H1 receptor antagonist chlorphenir-
amine. This is evidence of the presence of histamine H1
receptor expressed endogenously in these glioma cells.5 In
addition, from the result of the [3H] mepyramine binding to H1
receptor in cell membranes isolated from C6 glioma cells, the
data revealed a significant specific binding.
The presence of histamine H1 receptors on glial cells was
firstly indicated by studies of the binding of [3H] histamine
and [3H] mepyramine to glial cells in explant cultures from rat
brain.11 [3H] mepyramine binding studies had since revealed
the presence of H1 receptors on rat astrocytes in vitro,
12 and
activation of these receptors had been shown to stimulate
phosphoinositide hydrolysis.13
Since histamine plays an important physiologic role in
central14 and peripheral systems,15 and is involved in inflam-
matory or allergic syndromes of many reactions, there is
a need for more detailed studies of its second messengers in
the cells. We used C6 glioma cells to study the involvement of
these candidates, including calcium movement, AA metabo-
lism, and other phospholipid metabolism in the signal trans-
duction system. If this cell line is a good model for such an
investigation, further studies on down-regulation, desensiti-
zation by histamine or other mediators can be performed,
including studies that examine the drug effect on the hista-
minergic receptor system.
2. Methods2.1. MaterialsThe radioisotopes used in this study, [1,2-3H] L-myoinositol
(45.8 Ci/mmole), [3H] AA (100 Ci/mmole), [3H]mepyramine
(24.7 Ci/mmole) were purchased from New England Nuclear
(NEN) Co. (Boston, MA, USA). Other chemicals, histamine
HCl, chlorpheniramine, 3, 4, 5-tri-methoxy-benzoic acid 8-
(diethyl amino) octyl ester (TMB-8), lanthanum chloride,
sodium fluoride, aluminium chloride, fura-2/AM, nifedipine,
verapamil were purchased from Sigma Chemical Co. (St.
Louis, MO, USA); SK&F 96365 was obtained from BIOMOLResearch Laboratories, Inc. (Plymouth Meeting, PA, USA).
Ready Safe Liquid Scintillation Cocktail was obtained from
Beckman Co. (Fullerton, CA, USA) for Beckman LS-3801
model sample counting use. Additionally, a Cation Counter
(Spex Model CMIT 111; SPEX Industries, Edison, NJ, USA)
was used in this study.2.2. Cell cultureThe C6 glioma cell line was a gift from Professor Teh-
Cheng Chou at the Institute of Neuroscience at the National
Yang-Ming University (Taipei, Taiwan). These cells were
cultured in Ham’s F-10 medium (JRH Biosciences, Inc.,
Lenexa, KS, USA) with 10% fetal bovine serum (Hyclone Co.,
Logan, UT, USA). Cells in T-75 flasks (BD Biosciences,
Franklin Lakes, NJ, USA) were kept at 37 C, 5% CO2 and
95% O2 incubator. The culture medium was changed every
other day. This cell line has been used widely for decades
since its establishment in 1968.12.3. Methods for cell growth in experimentsC6 glioma cells were seeded on three glass cover slips
(10  40 mm) and kept in a 60-mm culture flask, and then the
flask was kept in an incubator until cell growth reached
a confluent state. Before the experiment, the medium was
changed to F-10 culture medium without addition of 10%
fetal bovine serum. Labeled materials were added to each
flask for a period of time, and then washed out unlabeled
portion with washing buffer [containing NaCl (116 mM),
NaHCO3 (26.2 mM), NaH2PO4 (1 mM), KCl (2.5 mM),
MgSO4 (1.5 mM), CaCl2 (2.5 mM), and glucose (20 mM)]
three times.2.4. PI turnover study5,16Labeled [3H] myo-inositol (1 mCi/ml) was added into each
flask for a 24-hour incubation in a F10 culture medium
without 10% fetal bovine serum. At the end of incubation,
this culture medium was removed and a washing buffer was
used to wash these cells three times. A 2.475 ml of buffer
solution was added into incubation flask and maintained/kept
at 37 C for 40 minutes. Then, 10 mM LiCl was added to
prevent the breakdown of inositol phosphated into inositol.
After that, a stimulator such as histamine was added into the
flask for 60 minutes. At the end of incubation, an ice cold
washing buffer was used to wash twice to end the reaction in
the flask. The glass plates were removed for counting and
kept in a scintillation counting vial. For further extraction of
inositol phosphates, the method of Pearce and colleagues17
was used.2.5. Analysis of GPI and PI5The PI products were analyzed with anion-exchange chro-
matography. 0.5 ml of AGI  8 resin (100e200 mesh, formate
form) was kept in a Pasteur pipette to form a column. Diluted
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column, and the PI was combined with resin. Then, 10 ml of
double-distilled water was added to wash out the free form of
PI. Then, 6 ml of 60 mM sodium formate/5 ml sodium tetra-
borate was added to wash the [3H] glycerol-phosphoinositol
([3H] GPI) out, and the first 2 ml was collected in a scintilla-
tion vial. Finally, 2 ml of 0.2 M ammonium formate/0.1 M
formic acid solution were added to wash out the [3H]IP1. The
fluid was collected in scintillation vials, then mixed well with
6 ml of scintillation fluid for scintillation vial counting.2.6. AA metabolism study18C6 glioma cells were plated at a concentration of
5  105 cells on a 35-mm incubation plate, kept at 37 C and
supplied with a 5% CO2 and 95% O2 incubator for 2 days until
the cells reached confluent state (about 1.5  106 cells). Then
the cultured medium was changed to medium containing [3H]
AA (0.15 mCi/ml) of F-10 cultured medium (not containing
bovine serum albumin) and kept at 37 C incubator for 24
hours to label the cells with radioisotope material. Before the
reaction was started, the radioisotope material was removed
and washed five times with washing buffer containing NaCl
(118 mM); KCl (4.7 mM); glucose (10 mM); [4-(2-hydrox-
yethyl)-1-piperazineethanesulfonic acid (HEPES) buffer
(20 mM) pH7.4 at 37 C. Following this, 2.475 ml buffer
solution (composition shown before) plus 25 ml of test sample
at the selected concentration was added to start the reaction at
37 C. At the end of reaction time, 1 ml of cell culture medium
was removed, placed in a centrifuge tube and centrifuged at
200  g for 10 minutes to precipitate the cells. After centri-
fugation, 1 ml of supernatant was removed and 3 ml of scin-
tillation counter fluid was added and mixed prior to counting
with scintillation counter.2.7. Intracellular calcium determination19C6 glioma cells in 10 ml of loading buffer (containing
150 mM NaCl, 5 mM KCl, 2.2 mM CaCl2, 1 mM MgCl2,
5 mM glucose, and 10 mM HEPES buffer at pH7.4) were kept
in centrifuge tubes and centrifuged at 750  g for 3 minutes,
and the pellet was washed twice with washing buffer. The cells
(1  107 cells/ml) were removed and 5 mM fura-2/AM was
added and then kept at 37 C for 45 minutes before centrifu-
gation. The supernatant was then removed, and cells were
washed with loading buffer twice to remove the remaining
fura-2/AM. The remaining cells were suspended with loading
buffer at a concentration of 5  106 cells/ml and kept in
a 15-ml plastic centrifuge tube. It was covered with aluminum
foil to prevent light penetration. The tube was in a dark
condition during the assay period. At the end of experiment,
0.3% digitonin was added to make fura-2 combined with Ca2þ
to obtain Rmax, and ethylene diamine tetraacetic acid (EGTA)
was added to a final concentration of 0.1 M to complete with
fura-2 for Ca2þ to obtain Rmin. Intracellular calcium concen-
tration was obtained by using the method of Grynkiewicz and
colleagues.162.8. [3H] mepyramine binding assay12Cell membranes (about 150 mg of membrane protein in
0.4 ml) prepared from C6 glioma cells, using the method of
Smit and colleagues,21 were incubated with 12 nM [3H]
mepyramine at 25 C for 60 minutes: one set with the pres-
ence of 1 mM chlorpheniramine as a nonspecific binding and
in another set without the presence of chlorpheniramine as
a total binding. At the end of incubation, 5 ml of cold washing
buffer was added to each tube to stop the reaction. Then the
whole volume of the reaction mixture was poured through the
GG/B filter paper (the filter papers were soaked with 1 mM
mepyramine solution prior to use) under the vacuum pump
and then washed twice with 4 ml washing buffer. The filter
papers kept in counting vials were dried for 1 hour at 30 C
before adding 3 ml of Ready Safe scintillation counter fluid
(Beckman Co., Fullerton, CA, USA). Then, these vials were
vortexed vigorously for 3e5 minutes, and then we let them
stand for 30 minutes stately before being put in a beta counter
for counting.2.9. Data analysisIn this study, a two-sample t test was used for statistical
analysis; the significant difference was set as p < 0.05 between
the two groups in the comparison. Each experiment was carried
out in triplicate, and each test was repeated at minimum three
times.
3. Results3.1. Binding of [3H] mepyramine to H1 receptor in
membrane preparation of C6 glioma cellsCell membranes isolated from C6 glioma cells were incu-
bated with or without 100 mM chlorpheniramine in the pres-
ence of 12 nM [3H] mepyramine for binding assay. A 77%
specific binding (against 23% nonspecific binding) of labeled
ligand to H1 receptor sites (i.e., the percentage of [(3250 dpm/
tube of total binding minus 773 dpm/tube of nonspecific
binding)/3250 dpm/tube of total binding, n ¼ 4] under this
condition was observed (Table 1).3.2. Histamine-induced IP1 accumulation in C6 glioma
cellsAt 37 C and in the presence of 10 mM LiCl, histamine at
100 mM caused [3H] IP1 accumulation, and this response was
a time-dependent phenomenon. The maximal response of
histamine at this concentration was found at 60 minutes and
maintained at plateau level for about 10 minutes, and then the
response went down (Fig. 1A). From the concentration response
study, histamine at 100 mM caused a maximal response of
11.8-fold increase of IP1 accumulation with respect to the basal
level (Fig. 1B). Based on the experimental data, the EC50
(effective concentration in 50% response) was calculated as
4.1 mM.
Table 1
Specifically bound [3H] Mepyramine to Histamine H1 receptor sites in C6
Glioma cells.




[3H] mepyramine (n ¼ 4)
3250  182 773  38 77  3
Binding assay was performed on C6 glioma cells using 12 nM [3H] mepyr-
amine at 25 C for 60 minutes, as described in the Materials and Methods
sections. Values represent mean  SEM.
a For the total binding, 12 nM [3H] mepyramine only with cell membranes.
b For the nonspecific binding, 12 nM [3H] mepyramine plus 1 mM chlor-
pheniramine with cell membranes.
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C6 glioma cellsAt 37 C and in the presence of 10 mM LiCl, histamine at
100 mM caused [3H]GPI accumulation in a time dependent-
manner. The maximal response was found at 60 minutes and
stayed at this plateau level up to 80 minutes (Fig. 2A). Also,
this accumulation response of GPI in the presence of hista-
mine was a concentration-dependent phenomenon. Based on
the data obtained, there was a 2.2-fold increase at maximal
response with respect to basal level, and the EC50 value was
calculated as 2.8 mM (Fig. 2B).3.4. Histamine-induced AA and its metabolite
accumulation in C6 glioma cellsFig. 1. (A) Time course of histamine-stimulated [3H] IP1 accumulation in C6
glioma cells. [3H] Inositol-labeled cells were incubated for the indicated
period of time with vehicle (H2O) (A) or 100 mM histamine (⌧) in theAt 37 C and in the presence of 100 mM of histamine, there
was a time-dependent increase of AA and its metabolite
accumulation (Fig. 3A). Histamine-induced maximal response
of AA accumulation at 60 minutes. This was a 1.6-fold
increase over the basal level (Fig. 3B). The EC50 value was
calculated as 2.8 mM.presence of 10 mM LiCl; (B) concentration-dependence of histamine-
stimulated accumulation of IP1 in C6 glioma cells. [
3H] Inositol-labeled
cells were washed, and exposed to the indicated concentrations of histamine
3.5. Histamine-induced intracellular calcium increase in
C6 glioma cellsin the presence of 10 mM LiCl for 60 minutes. Results are expressed
as percentage of basal level (4108  160 dpm/106 cells). Values are
mean  SEM from three independent experiments performed in triplicate.At 37 C and in the presence of varying concentrations of
histamine, there was a concentration-dependent increase of
a [Ca2þ]i. The increase was observed in two phases. The first
phase of increase was transient and happened within 1e2
seconds, and the second phase of increase was sustained, lasting
from 2 seconds to more than 1 minute. For transient phase,
a maximal response was seen at 100 mM of histamine (in-site
free calcium concentration of the cells was 730  80 nM). The
EC50 was 4.9 mM. For the sustained phase, the maximal
calcium increase was observed at 3.3 mM of histamine. The
calculated EC50 was 0.63 mM. The maximal responses lasted
more than 30 minutes (data not shown). If 100 mM of histamine
antagonist chlorpheniramine was added, the sustained level of
calcium concentration was found decreased to basal level
(Fig. 4A). In addition, all the histamine-induced biologic
response observed in this study could be completely blocked by
chlorpheniramine (Fig. 4B and Table 2).3.6. Mechanistic studies of histamine-induced
intracellular cellular responses
3.6.1. Effect of calcium chelator EGTA on histamine-
induced intracellular calcium increase
In the presence of 2 mM of EGTA, the transient phase of
intracellular calcium increase was inhibited by 20% only,
whereas sustained phase of intracellular calcium increase was
inhibited by 95% (Fig. 5A). Under these conditions, GPI
accumulation was inhibited by 80% (Table 3). It is clear that
80% or more of the transient phase of calcium increases
observed in the transient phase were from cellular storage
sites, whereas intracellular calcium increases seen in the sus-
tained phase were derived mainly from extracellular sources.
The influx of calcium into the cells caused the activation of
Fig. 3. (A) Time course of histamine-stimulated the release of arachidonic acid
(AA) and its metabolites into extracellular medium in C6 glioma cells. [3H]
AA-labeled cells were washed and incubated with 100 mM histamine (A), or
vehicle (⌧) for the indicated period of time; (B) concentration-dependence of
histamine-stimulated release of AA metabolites in C6 glioma cells. [3H] AA-
labeled cells were washed and exposed to the indicated concentrations of
histamine for 60 minutes. Results are expressed as percentage of basal level
(1105  60 dpm/106 cells). Values are the mean  SEM from three inde-
pendent experiments performed in triplicate.
Fig. 2. (A) Time course of histamine-stimulated [3H] GPI accumulation in C6
glioma cells. [3H] Inositol-labeled cells were washed and incubated for the
indicated period of time with either vehicle (A) or 100 mM histamine (⌧) in
the presence of 10 mM LiCl; (B) concentration-dependence of histamine-
stimulated accumulation of GPI in C6 glioma cells. [3H] Inositol-labeled
cells were washed and incubated with the indicated concentrations of hista-
mine in the presence of 10 mM LiCl for 60 minutes. Results are expressed as
percentage of basal level (884  69 dpm/106 cells). Results are mean  SEM
from three independent experiments performed in triplicate.
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accumulation.
3.6.2. Effect of calcium channel blocker La3þ on histamine-
induced intracellular calcium response
The addition of 1 mM La3þ completely blocked a hista-
mine-induced sustained calcium increase (Fig. 5B). This is
evidence that the sustained phase of intracellular free calcium
ion increase is a result of calcium influx from extracellular
sources.
3.6.3. Effect of receptor-mediated calcium channel blocker
(RMCE) on histamine-induced calcium response
In the presence of 10 mM SKF 96365, a receptor-mediated
calcium entry inhibitor,22 histamine-induced transient phaseof calcium increase was inhibited by about 20%, whereas sus-
tained calcium increases were inhibited by 67% (Fig. 6A).
However, L-type calcium channel blockers such as nifedipine or
verapamil did not block sustained calcium phase. Higher KCl
concentrations did not cause intracellular calcium increase (data
not shown). This observation demonstrated that histamine-
induced sustained calcium increase was not due to the
opening of the voltage-dependent calcium channel, but rather
the opening of receptor-mediated calcium channels.
3.6.4. Effects of intracellular calcium antagonist TMB-8 on
histamine-induced calcium response
Under the presence of 100 mM of TMB-8, an intracellular
calcium antagonist and a calcium influx blocker, histamine-
induced transient-phase calcium increases were inhibited by
83%, and histamine-induced sustained-phase calcium increases
were inhibited by 80% (Fig. 6B).
Fig. 5. (A) Exposure of cells to EGTA before challenging with histamine.
Assay conditions are detailed in the Materials and Methods section. EGTA
(2 mM final concentration) was added to bathing solution followed by hista-
mine (100 mM). H ¼ histamine, ch ¼ chlorpheniramine (100 mM), a trace:
without EGTA, b trace: with EGTA; (B) inhibitory effect of La3þ on
histamine-induced sustained elevation of [Ca2þ]i. Assay conditions are
detailed in the Materials and Methods section. Fura-2-loaded cells were
challenged with 100 mM histamine. Subsequently, La3þ (1 mM final
concentration) was added. EGTA ¼ ethylene diamine tetraacetic acid.
Fig. 4. (A) Concentration-response relationship of histamine-induced peak;
and (B) sustained elevation of [Ca2þ]i. Assay conditions are detailed in the
Materials and Methods section. Fura-2-loaded cells were challenged with
the indicated concentrations of histamine. [Ca 2þ]i ¼ intracellular free
calcium ion.
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From the [3H] mepyramine binding data, the C6 glioma cell
contains endogenous H1 receptors. Under 12 nM of labeled
mepyramine (a concentration close to the Kd (dissociationTable 2
Effects of H1 receptor antagonist on Histamine-induced IP1 accumulation, GPI
accumulation, and AA release and elevation of [Ca2þ].
Treatment IP1 Peak [Ca
2þ] GPI AA
Basal level (%)
H 1185  71 729  57 200  14 186  7
H þ Chor (C) 100  5a 100  3a 100  5a 100  3a
[3H] Inositol-labeled (for IP1 and GPI assay) or [
3H] AA-labeled (for AA
assay) cells were washed and pretreated with 100 uM chlorpheniramine (Chor)
or vehicle for 5 minutes prior to stimulation of 100 uM histamine for 60
minutes. And fura-2-loaded cells were washed and pretreated with vehicle or
100 uM chlorpheniramine for 1 minutes prior to stimulation of 100 uM
histamine. Results are expressed as percentage of basal level. Values are
mean  SEM from three independent experiments performed in triplicate or
n ¼ 4 experiments for calcium assay.
[Ca 2þ]i¼ intracellular free calcium; AA¼ arachidonic acid and its metabolites;
C ¼ chlorpheniramine; GPI ¼ glycerophosphoric-inositol; H ¼ histamine;
IP1 ¼ inositol 4-phosphate; Peak ¼ transient or peak increase in [Ca 2þ]i.
a Significant difference ( p < 0.05) from values in histamine only; in each
assay, basal level ¼ 100%.
Table 3
Effects of EGTA and SK&F 96365 on Histamine-induced IP1 accumulation,












1164  100 207  10 750  51 200  9
With 2 mM EGTA 1168  112 41  5a 600  20a 10  2a
With 10 uM Sk&F
96365
1175  100 68  8a 600  25a 60  5a
[3H] Inositol-labeled cells (for GPI and IP) were washed and pretreated with
vehicle (H2O), 2 mM EGTA or 10 uM of SK&F 96365 for 5 minutes prior to
stimulation of 100 uM histamine for 60 minutes in the presence of 10 LiCl.
And fura-2-loaded cells (for transient and sustained [Ca2þ]i ) were washed and
pretreated with vehicle (H2O), 2mM EGTA or 10 uM of SK&F 96365 for 5
minutes prior to stimulation of 100 uM of histamine. Results are expressed as
percentage of basal level. Values are mean  SEM from three independent
experiments.
[Ca 2þ]i ¼ intracellular free calcium ion; EGTA ¼ ethylene diamine tetra-
acetic acid; GPI ¼ glycerophosphoric-inositol; IP1 ¼ inositol 4-phosphate.
a Significant difference ( p < 0.05) from the values of vehicle treatment.
Fig. 6. (A) Exposure of cells to SK&F 96365 before challenging with hista-
mine. Assay conditions are detailed in the Materials and Methods section.
SK&F 96365 (10 mM final concentration) was added to bathing solution fol-
lowed by histamine (100 mM), a trace: without SK& F 96365, b trace: with
SK&F 96365; (B) inhibitory effect of 3,4,5-trimethoxybenzoic acid 8-(dieth-
ylamino)octyl ester (TMB-8) on histamine-induced elevation of [Ca2þ]i.
Assay conditions are detailed in the Materials and Methods section. When
pretreated, fura-2-loaded cells were incubated with the indicated concentration
of TMB-8 for 3 minutes followed by addition of histamine (100 mM).
H ¼ histamine, ch ¼ chlorpheniramine (100 mM).
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receptors in the primary astrocyte cell study,12 a 77% specific
binding (standing for H1 receptor sites) was observed, and
a 23% nonspecific binding was found under this assay
condition. This result revealed H1 receptors exist in the cells,
and these receptors can be detected by histamine H1 receptor–
specific ligand.
The lack of significant [3H]mepyramine binding toC6 glioma
cells reported in previous studies suggested a low density of
endogenous H1 receptors in these cells.
7,11 However, under
proper assay conditions, the specific binding sites still could be
found. These endogenous H1 receptors are very efficient in
coupling to related secondary messengers via G proteins to
perform different cellular responses.20
Stimulation of histamine H1 receptor by histamine can
activate PI-PLC to increase IP1 accumulation and intracellular
[Ca2þ]i via a pertussis toxin-insensitive G protein.22,23 Our data
confirmed the existence of H1 receptors in C6 glioma cells,
which are coupled to PI turnover, as reported by Peakman and
Hill5 in the use of [3H] inositol as a precursor in their PI turn-
over study.Histamine-induced IP1 accumulation in C6 glioma cells
with an EC50 of 4.2 mM caused more than an 11-fold increase
over the basal level at maximal response of 100 mM histamine.
The EC50 value obtained in this study is comparable with that
of related glial cells and other cells used in the previous studies,
such as U373 MG astrocytoma (EC50 ¼ 5.4 mM),24 DDT1
MF-2 (EC50 ¼ 10 mM),25 astrocyte-enriched primary culture
(EC50 ¼ 1.7 mM),13 oligodendroglioma (EC50 ¼ 1.6 mM),26
and C6 glioma cells (EC50 ¼ 24 mM5).
Histamine-induced transient [Ca2þ]i increase, with an EC50
of 4.9 mM, was higher than its sustained [Ca2þ]i increase, with
EC50 of 0.63 mM. The sensitivity of histamine-induced sus-
tained calcium phase increase is different from that of transient
calcium phase increase. Similar phenomenon has been found in
human neuroblastoma cells27 and parotid acinar cells.28
In the presence of 2 mM EGTA, a 20% inhibition of
histamine-induced transient [Ca2þ]i increase was observed,
whereas a 95% inhibition of histamine-induced sustained
[Ca 2þ]i increase was found when compared with the data of the
medium without EGTA. These results revealed that about 80%
of histamine-induced transient Ca2þ increase is from intracel-
lular storage sites, and its sustained phase calcium ion increase
is from extracellular calcium ion influx, since this effect could
be blocked in the presence of 1 mM La3þ. In the presence of
10 mM of SK&F 96365,9 histamine-induced transient calcium
ion increase could be reduced by 20%, whereas sustained
calcium ion increase was reduced by 70%. In the presence of
100 uM 3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl
ester (TMB-8), both transient calcium and sustained phase of
calcium level increases were reduced by 83 and 80%, respec-
tively. This is consistent with reports that TMB-8 is a calcium
influx blocker and an intracellular calcium antagonist.29
In this study, higher extracellular potassium levels were
unable to cause an increase in intracellular calcium. In addi-
tion, L-type voltage dependent calcium channel blockers
nifedipine and verapamil were unable to reduce sustained
calcium ion increase by histamine (data not shown). This is
evidence that sustained calcium increase induced by histamine
was from H1 receptor-mediated calcium channels, rather than
from voltage- dependent calcium channels.
Histamine-induced GPI accumulation and AA with its
metabolite release had an EC50 value of 2.8 mM. It is an
indication that both GPI and AA, with its metabolite accu-
mulation, are mediated by the PI hydrolysis pathway via
a receptor-coupled G protein system (likely a pertussis toxin-
sensitive G protein) to activate PLA2. However, histamine-
induced IP1 accumulation, and its EC50 value was 4.2 mM
(versus 2.8 mM obtained in GPI accumulation), indicates that
it may couple to a different G-protein (likely a pertussis toxin-
insensitive G protein) to activate phosphatidylinositol-
phospholipase C (PI-PLC). In the literature, histamine H1
receptor activation was found by Murayama and colleagues30
to be mediated via a pertussis toxin-sensitive G-protein and
subsequently activate PLA2 in rabbit platelets. Furthermore,
Brooks and coworkers31 proposed that the activation of PLA2
is coupled to influx of external calcium but not to mobilization
of intracellular calcium in C62B glioma cells. Here, influx of
150 C.-L. Tseng, J.-W. Wei / Journal of the Chinese Medical Association 75 (2012) 143e150external calcium caused by histamine is likely through acti-
vation of Gq/11 protein in PI-PLC pathway.
From the clinical point of view, our data results revealed
that the chemical mediator of histamine can interact with its
receptors in glioma cells and increase the AA metabolisms
and the prostaglandin levels in these cells. Hence, it is well
documented that abnormal metabolisms of arachidonic acid
and its metabolites are intimately linked to cancer biology.32
Further studies on this aspect are needed.
In conclusion, in C6 glioma cells, histamine interacted with
histamine H1 receptors and caused the activation of PI-PLC,
resulting in IP1 accumulation and intracellular calcium ion
increase. Also, it activated PLA2 and resulted in GPI accu-
mulation and AA release. Many physiologic events can
happen after the increase of [Ca2þ]i, inositol phosphates and
AA with metabolite release. Since this cell line uses many
secondary messengers of histamine to express the cell
responses, it is worthwhile to further study receptor desensi-
tization and/or down-regulation after prolonged activation of
H1 receptors. In addition, studies on which chemicals that can
activate or inhibit this signal transduction pathway, and they
may become some useful therapeutic agents.
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